1-3 of 3
Joseph E. Maakaron
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Joseph E. Maakaron, Adam Asch, Leslie Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colm Keane, Matthew Ku, Amitkumar Mehta, Mark Roschewski, Gal Hacohen-Kleiman, Yanan Huo, Yi Zhang, Camille Renard, Sonali M. Smith, Ranjana Advani
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5864–5874.
https://doi.org/10.1182/bloodadvances.2024013338
Published: 2024
Includes: Supplemental data
Journal Articles

An immunocompetent model to uncover the secrets of bispecifics

Joseph E. Maakaron
Journal: Blood Advances
Blood Adv (2024) 8 (2): 482–483.
https://doi.org/10.1182/bloodadvances.2023012027
Published: 2024
Journal Articles

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

Shakthi T. Bhaskar, Vivek G. Patel, David L. Porter, Stephen J. Schuster, Loretta J. Nastoupil, Miguel-Angel Perales, Ana Alarcon Tomas, Michael R. Bishop, Joseph P. McGuirk, Richard T. Maziarz, Andy I. Chen, Veronika Bachanova, Joseph E. Maakaron, Peter A. Riedell, Olalekan O. Oluwole
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4765–4772.
https://doi.org/10.1182/bloodadvances.2022008937
Published: 2023